Patients with non-valvular AFib were randomized to undergo treatment with the new-look AnchorMan or the Watchman 2.5. A follow-up study comparing the AnchorMan to the Watchman FLX and FLX Pro devices is already planned.

The same device was previously recalled back in 2022. Customers are urged to return unused delivery systems to Medtronic to avoid any issues.

The daily polypill was also associated with improved drug adherence, according to new research out of UT Southwestern.